Position
Entropy Technologies, LP in Arcutis Biotherapeutics, Inc.
Back to the book · All holders of ARQT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$66.5K$29.04 → $23.56
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.1K | $352.7K | — | — | — | 0.0% |
| Q1 2026 | 18K | $423.2K | $23.56 | −$66.5K | $137.1K | 0.0% |